Sabah Lubna, Moltke Finn Borgbjerg, Moffatt Christine J, Thomsen Simon Francis
Department of Dermato-Venereology & Wound Healing Center, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Centre for Research and Implementation of Clinical Practice, London, UK.
Pain Pract. 2025 Apr;25(4):e70029. doi: 10.1111/papr.70029.
Patients with lower extremity wounds often experience neuropathic pain; however, there is no validated assessment tool to specifically measure wound-related neuropathic pain. The study aimed to assess the prevalence of neuropathic pain in lower extremity wounds using different assessment tools and to identify factors associated with neuropathic pain.
A cross-sectional study of 130 patients with lower extremity wounds of different etiologies assessed neuropathic pain through clinical examinations, the Short Form McGill Pain Questionnaire-2 (SF-MPQ-2), and the Douleur Neuropathique 4 Questions (DN4). Pain intensity was measured using the Visual Analog Scale (VAS).
In total, 38 (29%) experienced neuropathic pain (DN4 score ≥ 4), and 75% (n = 97) described pain using one or more neuropathic pain descriptors on the SF-MPQ-2. The frequently reported descriptors on the neuropathic sub-scale were "pain caused by light touch" (59%) and "tingling or pins and needles" (49%). There was a positive correlation between DN4 and the neuropathic sub-scale of SF-MPQ-2, and the major difference between the tools is the design and time consumption. Univariate analysis revealed that younger age, arterial wound type, infection, and morphine consumption were associated with neuropathic pain (DN4 score ≥ 4). In multivariate analysis, arterial wound type increased the risk of neuropathic pain five-fold. Younger age and morphine consumption were also significantly associated with neuropathic pain, whereas infection was not.
Neuropathic wound pain is frequent, and the prevalence relies on the applied assessment tool. Arterial wound type, younger age, and morphine consumption are associated with neuropathic wound pain.
下肢伤口患者常经历神经性疼痛;然而,尚无经过验证的专门用于测量与伤口相关的神经性疼痛的评估工具。本研究旨在使用不同评估工具评估下肢伤口神经性疼痛的患病率,并确定与神经性疼痛相关的因素。
一项对130例不同病因的下肢伤口患者进行的横断面研究,通过临床检查、简式麦吉尔疼痛问卷-2(SF-MPQ-2)和神经病理性疼痛4问题(DN4)评估神经性疼痛。使用视觉模拟量表(VAS)测量疼痛强度。
共有38例(29%)经历神经性疼痛(DN4评分≥4),75%(n = 97)在SF-MPQ-2上使用一种或多种神经性疼痛描述词描述疼痛。在神经性子量表上经常报告的描述词是“轻触引起的疼痛”(59%)和“刺痛或麻木感”(49%)。DN4与SF-MPQ-2的神经性子量表之间存在正相关,这些工具之间的主要差异在于设计和耗时。单因素分析显示,年龄较小、动脉伤口类型、感染和吗啡使用与神经性疼痛(DN4评分≥4)相关。多因素分析显示,动脉伤口类型使神经性疼痛风险增加五倍。年龄较小和吗啡使用也与神经性疼痛显著相关,而感染则不然。
神经性伤口疼痛很常见,患病率取决于所应用的评估工具。动脉伤口类型、年龄较小和吗啡使用与神经性伤口疼痛相关。